$CPSS
CONSUMER PORTFOLIO SERVICES, INC. Stock $cpss

$cpss Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000168316824007729 Filed on November 07, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$100.6M
YoY Change		9.23%
Cost Of Revenue		$50.06M
YoY Change		32.07%
Gross Profit		$45.02M
YoY Change		-6.59%
Gross Profit Margin		44.76%
Selling, General & Admin		$19.00M
YoY Change		3.4%
% of Gross Profit		42.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$214.0K
YoY Change		7.54%
% of Gross Profit		0.48%
Operating Expenses		$93.73M
YoY Change		20.38%
Operating Profit		-$48.71M
YoY Change		64.21%
Interest Expense		$50.06M
YoY Change		32.11%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income		$6.851M
YoY Change		-51.81%
Income Tax		$2.055M
% Of Pretax Income		30.0%
Net Earnings		$4.796M
YoY Change		-53.79%
Net Earnings / Revenue		4.77%
Basic Earnings Per Share		$0.22
Diluted Earnings Per Share		$0.20
COMMON SHARES
Basic Shares Outstanding	21.41M shares	21.33M shares
Diluted Shares Outstanding		24.15M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$8.071M
YoY Change		-2.76%
Cash & Equivalents		$8.071M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$7.788M
Other Receivables		$0.00
Total Short-Term Assets		$15.86M
YoY Change		-62.77%
LONG-TERM ASSETS
Property, Plant & Equipment		$1.078M
YoY Change		-16.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$40.90M
YoY Change		57.96%
Total Long-Term Assets		$3.447B
YoY Change		21.44%
TOTAL ASSETS
Total Short-Term Assets		$15.86M
Total Long-Term Assets		$3.447B
Total Assets		$3.463B
YoY Change		20.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$49.68M
YoY Change		-14.34%
Accrued Expenses		$22.60M
YoY Change		438.12%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$72.28M
YoY Change		16.21%
LONG-TERM LIABILITIES
Long-Term Debt		$3.105B
YoY Change		21.65%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$3.105B
YoY Change		21.65%
TOTAL LIABILITIES
Total Short-Term Liabilities		$72.28M
Total Long-Term Liabilities		$3.105B
Total Liabilities		$3.178B
YoY Change		21.52%
SHAREHOLDERS EQUITY
Retained Earnings		$261.9M
YoY Change		8.83%
Common Stock		$25.04M
YoY Change		-11.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$285.1M
YoY Change
Total Liabilities & Shareholders Equity		$3.463B
YoY Change		20.2%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$4.796M
YoY Change		-53.79%
Depreciation, Depletion And Amortization		$214.0K
YoY Change		7.54%
Cash From Operating Activities		$69.76M
YoY Change		13.99%
INVESTING ACTIVITIES
Capital Expenditures		$100.0K
YoY Change		-50.0%
Acquisitions
YoY Change
Other Investing Activities		-$218.9M
YoY Change		165.36%
Cash From Investing Activities		-$219.0M
YoY Change		164.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		161.7M
YoY Change		1848.16%
NET CHANGE
Cash From Operating Activities		69.76M
Cash From Investing Activities		-219.0M
Cash From Financing Activities		161.7M
Net Change In Cash		12.44M
YoY Change		-194.25%
FREE CASH FLOW
Cash From Operating Activities		$69.76M
Capital Expenditures		$100.0K
Free Cash Flow		$69.66M
YoY Change		14.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1372000	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1565000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3736000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	40899000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25861000	usd
CY2024Q3	us-gaap	Assets Assets	3462692000	usd
CY2023Q4	us-gaap	Assets Assets	2903746000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	72626000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	62544000	usd
CY2024Q3	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	105783000	usd
CY2023Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	234025000	usd
CY2024Q3	cpss	Residual Interest Financing ResidualInterestFinancing	99127000	usd
CY2023Q4	cpss	Residual Interest Financing ResidualInterestFinancing	49875000	usd
CY2024Q3	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	2875777000	usd
CY2023Q4	us-gaap	Subordinated Debt SubordinatedDebt	17188000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	3177601000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2629078000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4998130	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4998130	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	25043000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	28678000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	274668000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3462692000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2903746000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14058000	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8071000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6174000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2869000	usd
CY2024Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	7788000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1078000	usd
CY2023Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	2265446000	usd
CY2024Q3	us-gaap	Subordinated Debt SubordinatedDebt	24288000	usd
CY2024Q3	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	93158000	usd
CY2023Q3	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	83261000	usd
	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	265812000	usd
CY2024Q3	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-5500000	usd
CY2023Q3	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-6000000	usd
	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-16000000	usd
	cpss	Mark To Finance Receivables Measured At Fair Value MarkToFinanceReceivablesMeasuredAtFairValue	-6000000	usd
CY2024Q3	us-gaap	Other Operating Income OtherOperatingIncome	1922000	usd
CY2023Q3	us-gaap	Other Operating Income OtherOperatingIncome	2818000	usd
	us-gaap	Other Operating Income OtherOperatingIncome	6391000	usd
	us-gaap	Other Operating Income OtherOperatingIncome	8077000	usd
CY2024Q3	us-gaap	Salaries And Wages SalariesAndWages	24162000	usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages	21812000	usd
	us-gaap	Salaries And Wages SalariesAndWages	72303000	usd
	us-gaap	Salaries And Wages SalariesAndWages	64991000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13276000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13045000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	40288000	usd
CY2024Q3	us-gaap	Interest Expense Operating InterestExpenseOperating	50056000	usd
CY2023Q3	us-gaap	Interest Expense Operating InterestExpenseOperating	37889000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	138735000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	106354000	usd
	cpss	Provision For Credit Losses ProvisionForCreditLosses	20700000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5723000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5330000	usd
	us-gaap	Occupancy Net OccupancyNet	4250000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	642000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	93729000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	77861000	usd
	us-gaap	Operating Expenses OperatingExpenses	268123000	usd
	us-gaap	Operating Expenses OperatingExpenses	208784000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6851000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14218000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20080000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	51253000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2055000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3839000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6022000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13097000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	4796000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	10379000	usd
	us-gaap	Net Income Loss NetIncomeLoss	38156000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.83
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.51
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21343000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21154000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21250000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20815000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24153000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25218000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24340000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25331000	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	4796000	usd
	us-gaap	Net Income Loss NetIncomeLoss	38156000	usd
	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	164394000	usd
	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	143949000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	650000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	642000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7740000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7264000	usd
	cpss	Mark To Finance Receivable Measured At Fair Value MarkToFinanceReceivableMeasuredAtFairValue	-16000000	usd
	cpss	Mark To Finance Receivable Measured At Fair Value MarkToFinanceReceivableMeasuredAtFairValue	-6000000	usd
	cpss	Provision For Credit Losses ProvisionForCreditLosses	4579000	usd
	cpss	Provision For Credit Losses ProvisionForCreditLosses	20700000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2368000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2634000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2171000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4414000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15126000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4671000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10082000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6888000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	165758000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	181918000	usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-21475000	usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-56986000	usd
	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	1195886000	usd
	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	958587000	usd
	cpss	Payments Received On Finance Receivables At Fair Value PaymentsReceivedOnFinanceReceivablesAtFairValue	-637844000	usd
	cpss	Payments Received On Finance Receivables At Fair Value PaymentsReceivedOnFinanceReceivablesAtFairValue	-625715000	usd
	cpss	Change In Repossessions In Inventory ChangeInRepossessionsInInventory	-88000	usd
	cpss	Change In Repossessions In Inventory ChangeInRepossessionsInInventory	-411000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	356000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	277000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-536835000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-275752000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	1453921000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	949385000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	8784000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	usd
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	1684000	usd
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	6100000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-125566000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-46407000	usd
	cpss	Repayment Of Residual Interest Financing Debt RepaymentOfResidualInterestFinancingDebt	-0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	840480000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	14274000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6825000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15833000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	524698000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	73138000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	153621000	usd
	us-gaap	Interest Paid Net InterestPaidNet	129335000	usd
	us-gaap	Interest Paid Net InterestPaidNet	97812000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9552000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4389000	usd
	cpss	Rightofuse Asset Net RightofuseAssetNet	-21008000	usd
	cpss	Rightofuse Asset Net RightofuseAssetNet	-3983000	usd
	cpss	Lease Liability LeaseLiability	22944000	usd
	cpss	Lease Liability LeaseLiability	4307000	usd
	cpss	Deferred Office Rent DeferredOfficeRent	-1936000	usd
	cpss	Deferred Office Rent DeferredOfficeRent	-324000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	274668000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	285091000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	265896000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	285091000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	265896000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zEpaYgkezXqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_863_zzN6OCWdZVRa">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, as well as the reported amounts of income and expenses during the reported periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p>
CY2024Q3	us-gaap	Other Operating Income OtherOperatingIncome	1922000	usd
CY2023Q3	us-gaap	Other Operating Income OtherOperatingIncome	2818000	usd
	us-gaap	Other Operating Income OtherOperatingIncome	6391000	usd
	us-gaap	Other Operating Income OtherOperatingIncome	8077000	usd
CY2024Q3	cpss	Operating Lease Liability1 OperatingLeaseLiability1	22601000	usd
CY2023Q4	cpss	Operating Lease Liability1 OperatingLeaseLiability1	3220000	usd
CY2024Q3	cpss	Finance Lease Right Of Use Asset At Cost FinanceLeaseRightOfUseAssetAtCost	3794000	usd
CY2023Q4	cpss	Finance Lease Right Of Use Asset At Cost FinanceLeaseRightOfUseAssetAtCost	3474000	usd
CY2024Q3	cpss	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	3460000	usd
CY2023Q4	cpss	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	3385000	usd
CY2024Q3	cpss	Finance Lease Right Of Use Asset1 FinanceLeaseRightOfUseAsset1	334000	usd
CY2023Q4	cpss	Finance Lease Right Of Use Asset1 FinanceLeaseRightOfUseAsset1	89000	usd
CY2024Q3	cpss	Finance Lease Liability1 FinanceLeaseLiability1	343000	usd
CY2023Q4	cpss	Finance Lease Liability1 FinanceLeaseLiability1	93000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050	pure
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	3996000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	4181000	usd
CY2024Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	29000	usd
CY2023Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	70000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	139000	usd
CY2024Q3	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	6000	usd
CY2023Q3	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	1000	usd
	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	13000	usd
	cpss	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	5000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	727000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2400000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	816000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2600000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3700000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y3M18D
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000889609
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2024Q3	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
CY2023Q3	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
	cpss	Pension Benefit Obligation PensionBenefitObligation		usd
	cpss	Final Scheduled Payment Date FinalScheduledPaymentDate
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Entity File Number EntityFileNumber	001-11416
	dei	Entity Registrant Name EntityRegistrantName	CONSUMER PORTFOLIO SERVICES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0459135
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3800 Howard Hughes Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1400
	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89169
	dei	City Area Code CityAreaCode	949
	dei	Local Phone Number LocalPhoneNumber	753-6800
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	CPSS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21405198	shares
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	270981000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	119257000	usd
CY2024Q3	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	3132310000	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	2722662000	usd
CY2024Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	8274000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	27553000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	486000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	24684000	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21405198	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21405198	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21174856	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21174856	shares
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	261915000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	247857000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1867000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1867000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	285091000	usd
	us-gaap	Interest And Fee Income Loans Consumer InterestAndFeeIncomeLoansConsumer	245960000	usd
CY2024Q3	us-gaap	Revenues Revenues	100580000	usd
CY2023Q3	us-gaap	Revenues Revenues	92079000	usd
	us-gaap	Revenues Revenues	288203000	usd
	us-gaap	Revenues Revenues	260037000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36224000	usd
CY2024Q3	cpss	Provision For Credit Losses ProvisionForCreditLosses	994000	usd
CY2023Q3	cpss	Provision For Credit Losses ProvisionForCreditLosses	2000000	usd
	cpss	Provision For Credit Losses ProvisionForCreditLosses	4579000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16476000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16517000	usd
CY2024Q3	us-gaap	Occupancy Net OccupancyNet	1292000	usd
CY2023Q3	us-gaap	Occupancy Net OccupancyNet	1586000	usd
	us-gaap	Occupancy Net OccupancyNet	4756000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	214000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	199000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	650000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	10379000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14058000	usd
	us-gaap	Net Income Loss NetIncomeLoss	38156000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
CY2023Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	0	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4796000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-10379000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-14058000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-38156000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14058000	usd
	cpss	Repayment Of Residual Interest Financing Debt RepaymentOfResidualInterestFinancingDebt	-50000000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	814473000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5984000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12828000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19116000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20696000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125431000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	162789000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	279052000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142093000	usd
CY2024Q3	cpss	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	51093000	usd
CY2023Q4	cpss	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	29575000	usd
CY2024Q3	cpss	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	30419000	usd
CY2023Q4	cpss	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	26651000	usd
CY2024Q3	cpss	Operating Lease Right Of Use Asset1 OperatingLeaseRightOfUseAsset1	20674000	usd
CY2023Q4	cpss	Operating Lease Right Of Use Asset1 OperatingLeaseRightOfUseAsset1	2924000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1311000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1410000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3996000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	4181000	usd
CY2024Q3	cpss	Finance Lease Cost FinanceLeaseCost	34000	usd
CY2023Q3	cpss	Finance Lease Cost FinanceLeaseCost	18000	usd
	cpss	Finance Lease Cost FinanceLeaseCost	82000	usd
	cpss	Finance Lease Cost FinanceLeaseCost	144000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	1345000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	1428000	usd
	us-gaap	Lease Cost LeaseCost	4078000	usd
	us-gaap	Lease Cost LeaseCost	4325000	usd
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	1311000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	1410000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8125000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1700000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.01
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	270000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.30
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6155000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.41
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y10M28D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5145000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.75
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y7M17D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6155000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5145000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8125000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6062000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25900000	usd
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	24600000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8000000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	13500000	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2954000	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z7CDtgstis25" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86C_zOIhI9Wkkmml">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on net income or shareholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	8274000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	27553000	usd
CY2024Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	371000	usd
CY2023Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1100000	usd
CY2024Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	8274000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	27553000	usd
CY2024Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	684000	usd
CY2023Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	5721000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2869000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21753000	usd
CY2024Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-994000	usd
CY2023Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-2000000	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-4579000	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-20700000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	544000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1477000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1976000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	6391000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	1340000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	1984000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	4172000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	9566000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	486000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4228000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	486000	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	4228000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	544000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1477000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1976000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	6391000	usd
CY2024Q3	cpss	Gross Balance Of Repossessions In Inventory GrossBalanceOfRepossessionsInInventory	233000	usd
CY2023Q4	cpss	Gross Balance Of Repossessions In Inventory GrossBalanceOfRepossessionsInInventory	597000	usd
	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-195000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-472000	usd
CY2024Q3	us-gaap	Foreclosed Assets ForeclosedAssets	38000	usd
CY2023Q4	us-gaap	Foreclosed Assets ForeclosedAssets	125000	usd
CY2024Q3	cpss	Receivables Pledged ReceivablesPledged	3154293000	usd
CY2024Q3	cpss	Securitization Trust Debt Initial Principal SecuritizationTrustDebtInitialPrincipal	6691358000	usd
CY2024Q3	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	2893462000	usd
CY2023Q4	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	2280021000	usd
CY2024Q3	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	17700000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	14600000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	233347000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	301813000	usd
CY2024Q1	cpss	Securitization Of Residual Interests SecuritizationOfResidualInterests	50000000	usd
CY2024Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	50000000	usd
CY2024Q3	cpss	Securitization Of Residual Interests Outstanding SecuritizationOfResidualInterestsOutstanding	50000000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	873000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	125000	usd
CY2024Q3	us-gaap	Investment Income Net InvestmentIncomeNet	1516000	usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet	3769000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	5634000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	12809000	usd
CY2024Q3	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	89942000	usd
CY2023Q3	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	77848000	usd
	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	255546000	usd
	us-gaap	Interest Income Purchased Receivables InterestIncomePurchasedReceivables	228641000	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	1700000	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	1644000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	4632000	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	4510000	usd
CY2024Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	93158000	usd
CY2023Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	83261000	usd
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	265812000	usd
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	245960000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	50056000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	37889000	usd
	us-gaap	Interest Expense InterestExpense	138735000	usd
	us-gaap	Interest Expense InterestExpense	106354000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21343000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21154000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21250000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20815000	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2810000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	4064000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3090000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	4516000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24153000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25218000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24340000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25331000	shares
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1600000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1700000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1500000	shares
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1600000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1600000	usd
CY2024Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2100000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6000000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.30	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.30	pure
CY2023Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3800000	usd
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	13100000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.27	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.26	pure
CY2024Q3	cpss	Probable Legal Contingencies ProbableLegalContingencies	2300000	usd
CY2024Q3	cpss	Maximum Possible Losses For Legal Proceedings And Contingencies MaximumPossibleLossesForLegalProceedingsAndContingencies	4300000	usd
CY2024Q2	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2960375000	usd
CY2023Q2	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2618420000	usd
CY2023Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2722662000	usd
CY2022Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2476617000	usd
CY2024Q3	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	442126000	usd
CY2023Q3	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	300539000	usd
	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	1195886000	usd
	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	958587000	usd
CY2024Q3	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-217945000	usd
CY2023Q3	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-203775000	usd
	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-637844000	usd
	cpss	Payments On Finance Receivables At Fair Value PaymentsOnFinanceReceivablesAtFairValue	-625715000	usd
CY2024Q3	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	57746000	usd
CY2023Q3	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	49644000	usd
	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	164394000	usd
	cpss	Net Interest Income Accretion On Fair Value Receivables NetInterestIncomeAccretionOnFairValueReceivables	143949000	usd
CY2024Q3	cpss	Mark To Fair Value MarkToFairValue	5500000	usd
CY2023Q3	cpss	Mark To Fair Value MarkToFairValue	6000000	usd
	cpss	Mark To Fair Value MarkToFairValue	16000000	usd
	cpss	Mark To Fair Value MarkToFairValue	6000000	usd
CY2024Q3	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	3132310000	usd
CY2023Q3	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2671540000	usd
CY2024Q3	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	3132310000	usd
CY2023Q3	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2671540000	usd
CY2024Q3	cpss	Finance Receivables Contractual Balance FinanceReceivablesContractualBalance	3321329000	usd
CY2024Q3	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	3132310000	usd
CY2023Q4	cpss	Finance Receivables Contractual Balance FinanceReceivablesContractualBalance	2941915000	usd
CY2023Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2722662000	usd
CY2024Q3	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	3132310000	usd
CY2023Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	2722662000	usd
	cpss	Discount Rate On Finance Receivables DiscountRateOnFinanceReceivables	11.36%
CY2023	cpss	Discount Rate On Finance Receivables DiscountRateOnFinanceReceivables	11.35%
	cpss	Cumulative Net Losses On Finance Receivables CumulativeNetLossesOnFinanceReceivables	15.44%
CY2023	cpss	Cumulative Net Losses On Finance Receivables CumulativeNetLossesOnFinanceReceivables	15.25%
CY2024Q3	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	3321329000	usd
CY2023Q4	us-gaap	Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue	2941915000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8071000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	270981000	usd
CY2024Q3	cpss	Finance Receivables Fair Value Disclosure FinanceReceivablesFairValueDisclosure	6201000	usd
CY2024Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	91000	usd
CY2024Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	105783000	usd
CY2024Q3	cpss	Residuals Interest Financing ResidualsInterestFinancing	99127000	usd
CY2024Q3	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	9589000	usd
CY2024Q3	us-gaap	Secured Debt SecuredDebt	2897538000	usd
CY2024Q3	us-gaap	Subordinated Debt SubordinatedDebt	24288000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6174000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	119257000	usd
CY2023Q4	cpss	Finance Receivables Fair Value Disclosure FinanceReceivablesFairValueDisclosure	20848000	usd
CY2023Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	292000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	234025000	usd
CY2023Q4	us-gaap	Accounts Payable Fair Value Disclosure AccountsPayableFairValueDisclosure	7928000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	2183331000	usd
CY2023Q4	us-gaap	Subordinated Debt SubordinatedDebt	17188000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-007729-index-headers.html	Edgar Link	pending
0001683168-24-007729-index.html	Edgar Link	pending
0001683168-24-007729.txt	Edgar Link	pending
0001683168-24-007729-xbrl.zip	Edgar Link	pending
cpss-20240930.xsd	Edgar Link	pending
cps_ex3101.htm	Edgar Link	pending
cps_ex3102.htm	Edgar Link	pending
cps_ex3200.htm	Edgar Link	pending
cps_i10q-093024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
cpss-20240930_def.xml	Edgar Link	unprocessable
cpss-20240930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cps_i10q-093024_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cpss-20240930_cal.xml	Edgar Link	unprocessable
cpss-20240930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSS
CONSUMER PORTFOLIO SERVICES, INC. Stock $cpss

2024 Q4 Form 10-Q Financial Statement

#000168316824007729 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSS CONSUMER PORTFOLIO SERVICES, INC. Stock $cpss

2024 Q4 Form 10-Q Financial Statement

#000168316824007729 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSS
CONSUMER PORTFOLIO SERVICES, INC. Stock $cpss